secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2026-09-04T12:03:17+00:00
Accession:  0001628280-26-060614
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta receives full $35M vendor loan repayment, completing B Medical sale proceeds
--------------------------------------------------------------------------------

- Thelema repaid $35M vendor loan plus accrued interest, total $35,373,333, on Sept 3, 2026, prior to maturity.
- Loan from Azenta Germany GmbH to Thelema bore 6.0% interest, secured by B Medical equity pledge; pledge now released.
- With repayment, Azenta has received entire $63M purchase price for B Medical in cash.
- CEO Martin Madaus says repayment completes divestiture and retires credit exposure, supporting capital allocation discipline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000162828026060614/0001628280-26-060614-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000162828026060614/azta-20260903.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-060614

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer